Abstract
Ocular and adnexal lymphoma are a rare presentation of non-Hodgkin’s lymphoma (NHL). Radiation treatment particularly for ocular and adnexal lymphomas is technically challenging, because effort is made to prevent collateral damage to surrounding structures without compromising local control. Various studies have shown primary orbital lymphomas respond well to radiotherapy with an excellent local control rate (95–98%). The advantages of the radiotherapy treatment are a high-local control rate and durable disease-free status. Carefully planned radiation treatment for ocular and adnexal lymphoma is well tolerated by patients and without any sight threatening local complications. In this chapter, we will describe indications and various techniques available to deliver precise radiation for ocular and adnexal lymphoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
